What does a complete blood count (CBC) showing hemoglobin 11.4 g/dL, hematocrit 33.2 %, mean corpuscular hemoglobin concentration (MCHC) 37 g/dL, platelet count 461 ×10⁹/L, and 1 % myelocytes indicate?

Interpretation of CBC Results

These laboratory values indicate mild anemia with reactive thrombocytosis and the presence of immature myeloid cells (myelocytes), which requires immediate peripheral blood smear review and further evaluation to exclude a myeloproliferative disorder, infection, or bone marrow stress response.

Key Abnormalities Identified

Your CBC shows three significant findings that warrant attention:

1. Mild Normocytic Anemia

• Hemoglobin 11.4 g/dL is below the normal range (12.0 g/dL for women, 13.0 g/dL for men per WHO criteria) 1
• Hematocrit 33.2% is correspondingly low (normal: 36% for women, 39% for men) 1
• MCHC 37 g/dL is at the upper limit of normal or slightly elevated, which is unusual and may indicate:
  • Laboratory artifact or interference 2, 3
  • Hemolytic process
  • Spherocytosis
  • Cold agglutinins affecting measurement

2. Thrombocytosis

• Platelet count 461 × 10⁹/L exceeds the normal range (typically 150-450 × 10⁹/L)
• This level meets criteria for investigation per WHO guidelines (sustained platelet count ≥450 × 10⁹/L) 4

3. Left Shift with Myelocytes

• 1% myelocytes in peripheral blood is abnormal—these immature granulocytes should not normally be present
• This finding is termed "leukoerythroblastosis" when combined with other immature cells 5

Immediate Next Steps

Critical Actions Required:

1. Peripheral Blood Smear Review 6

   • Confirm red cell morphology (size, shape, color)
   • Verify presence and percentage of myelocytes
   • Look for other immature cells (metamyelocytes, blasts)
   • Assess for dysplastic changes
   • Evaluate platelet morphology

2. Complete the Anemia Workup 6

   • Reticulocyte count (corrected for anemia)—determines if bone marrow is responding appropriately
   • Iron studies: serum ferritin, transferrin saturation, serum iron, TIBC
   • Inflammatory markers: CRP, ESR
   • Vitamin levels: B12 and folate
   • Renal function: creatinine, BUN

3. Assess for Underlying Causes 6, 7

   • Infection/inflammation: fever, symptoms, white blood cell differential
   • Bleeding: occult blood loss, menstrual history, GI symptoms
   • Chronic disease: inflammatory conditions, malignancy
   • Bone marrow disorders: constitutional symptoms (night sweats, weight loss, early satiety)

Differential Diagnosis

For the Combined Picture:

Primary Concerns (Require Hematology Referral):

• Myeloproliferative neoplasm (MPN) such as:
  • Essential thrombocythemia (ET)—platelet count ≥450 × 10⁹/L with megakaryocyte proliferation 4
  • Primary myelofibrosis (PMF)—can present with anemia, thrombocytosis, and leukoerythroblastosis 5
  • Chronic myeloid leukemia (CML)—though typically presents with higher WBC 7
• Myelodysplastic syndrome (MDS)—dysplasia with cytopenias 6

Secondary/Reactive Causes:

• Reactive thrombocytosis due to:
  • Iron deficiency (most common cause of combined anemia + thrombocytosis) 4
  • Acute/chronic inflammation or infection
  • Tissue damage, surgery, or hemorrhage
  • Malignancy (solid tumors)
• Bone marrow stress response to:
  • Hemolysis
  • Acute blood loss
  • Severe infection

For the Elevated MCHC:

• Laboratory interference (lipemia, hemolysis, cold agglutinins) 2, 3
• Hereditary spherocytosis
• Autoimmune hemolytic anemia
• Severe dehydration (less likely with this degree of anemia)

When to Refer to Hematology

Immediate referral indicated if:

• Peripheral smear shows blasts (>1%), significant dysplasia, or abnormal cell morphology
• Multiple cytopenias present
• Splenomegaly on examination
• Constitutional symptoms (fever, night sweats, weight loss)
• No clear reactive cause identified

Urgent referral (within 2 weeks) if:

• Persistent unexplained thrombocytosis after treating iron deficiency
• Myelocytes persist on repeat CBC
• Anemia worsens or fails to respond to appropriate treatment

Clinical Pitfalls to Avoid

1. Don't dismiss the myelocytes—even 1% is abnormal and requires explanation 7, 8
2. Don't assume reactive thrombocytosis without excluding clonal disorders—check for JAK2 V617F mutation if thrombocytosis persists 4, 5
3. Don't ignore the elevated MCHC—verify with peripheral smear as it may indicate hemolysis or laboratory artifact 2
4. Don't treat empirically without workup—iron supplementation before checking iron studies can mask iron deficiency anemia and delay diagnosis of underlying conditions 6, 1
5. Don't forget to repeat the CBC—transient abnormalities from infection or stress should normalize within 2-4 weeks 8

Practical Algorithm

1. Today: Order peripheral smear, reticulocyte count, iron studies, CRP, B12/folate
2. Within 48-72 hours: Review smear results with pathologist
3. If smear shows dysplasia/blasts OR no reactive cause found: Refer to hematology
4. If iron deficiency confirmed: Treat and recheck CBC in 4 weeks
5. If reactive cause identified (infection, inflammation): Treat underlying condition and recheck CBC in 2-4 weeks
6. If thrombocytosis persists after 8-12 weeks: Consider JAK2 mutation testing and bone marrow biopsy 4, 5